Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study

Alessandro Rambaldi, Alessandra Iurlo, Alessandro M Vannucchi, Richard Noble, Nikolas von Bubnoff, Attilio Guarini, Bruno Martino, Antonio Pezzutto, Giuseppe Carli, Marianna De Muro, Stefania Luciani, Mary Frances McMullin, Nathalie Cambier, Jean-Pierre Marolleau, Ruben A Mesa, Raoul Tibes, Alessandro Pancrazzi, Francesca Gesullo, Paolo Bettica, Sara ManzoniSilvia Di Tollo

Research output: Contribution to journalArticle

1 Citation (Scopus)
21 Downloads (Pure)
Original languageEnglish
JournalLeukemia
Early online date11 Feb 2020
DOIs
Publication statusEarly online date - 11 Feb 2020

Cite this

Rambaldi, A., Iurlo, A., Vannucchi, A. M., Noble, R., von Bubnoff, N., Guarini, A., Martino, B., Pezzutto, A., Carli, G., De Muro, M., Luciani, S., McMullin, M. F., Cambier, N., Marolleau, J-P., Mesa, R. A., Tibes, R., Pancrazzi, A., Gesullo, F., Bettica, P., ... Di Tollo, S. (2020). Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study. Leukemia. https://doi.org/10.1038/s41375-020-0735-y